Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That chart just about sums it up, pair that up with the stellar daily volume, and the fact that every time news is released stock price tanks...Pretty clear this is a nothing company.
A pump and dump scam
You are correct. The court has ordered Dan to turn over the books and records. They have ruled the the shareholder meeting is presumed valid unless proven it isn’t.
I would expect Dan will file a motion to reverse the shareholder meeting due to the quorum requirement not being met as outlined in the most recent bylaws approved by the board, not sure why he didn't already do this? This will be very difficult for a judge to ignore as no court orders prevented the company from changing its bylaws at it sees fit and the petitioners failed to inquire if the bylaws had changed before calling their meeting.
As far as the asset and a first secured mortgage management you mention has supposedly secured, the asset was already lost to a similar first secured mortgage the same type you indicate has been secured.
This real property law fight is an entirely different legal fight coming here beyond Sarissa company control. The board of Noostar will have to stop RD Volusia from excersing it real property rights under the convertible note, in which the previous default and conveyance occurred.
Additionally RD Volusia has other default rights including default under a change of control provision to it. So at minimum the company will have to write a big check to RD Volusia.
This is likey to remain a mess for many years to come and eventually work on the property or cash will also be needed to hold the leases.
This is not close to being over but we should avoid a delisting, but the legal fights will prevent anything from ever happening here in the short to medium term if not forever.
Dan is still the president of Sarissa. Keevil and Currah’s shareholder meeting didn't meet the quorum requirements as outlined in the company bylaws at the time the meeting was called.
Keevil and Cutrah have ignored cease and desist orders from the company. They are illegally acting as officers and directors.
Keevil and Currah are causing the company to not be able to update OTCMARKETS with current financials also well a a significant financing for the project from closing.
Remember the asset is no longer owned by Sarissa as it was lost to a repossesion but due to Dan the shareholders are still going to benefit from a deal to move the project forward.
Dan is in court to get the judge to rule regarding the bylaws and also hold Keevil and Currah and their gang financially responsible for the damages they have done to the company.
We’ll see what happens. The only chance shareholders have is for Dan to win. Otherwise the mining projects futures won't be shared with Sarissa shareholders.
So like normal Keevil as Currah care only about themselves but what else is new.
Does anyone have a copy of the email sent out by Paul Rosenbaum soliciting funds from shareholders? It had a tiered breakdown if you owned this many shares, they were asking for this amount of money.
So prior to that he was quoting Bruce where he "expects" it to be a major growth. And then states an independent company valued IncellDX at $80m NO WHERE CLOSE to $350m.
Look at cytodyn. Cydy
Tim, $545 traded... That's all
Interesting I heard the issue was that shareholder meeting was invalid because Currah and Keevil and/or their lawyers never asked the company for the recent bylaws and didn't meet the existing quorum requirement.
Typical of Currah and Keevil to try and violate the law.
I know for a fact if Currah wasn't involved this project would already have been financed several times over.
Dan certainly hadn't delivered but he doesn't the problem here.
Min for nasdaq is $2. The higher the price the less requirements needed.
Sorry I misread, and thought you meant option 3
Tim-ber down 11%
Could this also be Paul???
"Trainer Bob Every of Lansing Community College has blasted attorney Paul Rosenbaum for his handling of Ms. Lafler's sex discrimination lawsuit, suggesting the former lawmaker is more interested in publicity than getting the young woman a chance to fight."
https://www.upi.com/Archives/1982/02/13/Female-boxers-trainer-blasts-lawyer/9815382424400/
This is further proof we need to have a BP partner, all of them are getting approvals no matter what they show.
She's listed on the website
You're missing the point, the pump and dump are over and has been trending downward for years. There was even an sec halt that lasted a few years.
You've been saying that for a while now... And the price and volume keep falling. There is no interest on the boards... Come on now
It's a scam, there is no interest. Everyone knows that do some homework
I believe we had the chance to run a trial with Gilead early on in the pandemic. This was the BIGGEST mistake by not taking their offer, and going at it alone. We would have for sure had an approval now and possibly a buy out or partnership with Gilead, at least for covid.
He's a scientist he value is in a lab setting. If the plan is to replace Nader, that individual better have a long history with biotechs and a successful one at that. Otherwise we're right where we are but with even more unknowns.
There was a (s) you listed an expert and I hope that group is not trying to bring him in as CEO...
I suppose it depends on the terms of the partnership with Incelldx. I'm NO way in favor of our company purchasing Incelldx as we have zero money for that, and it really won't benefit us.
I think the best thing that CYDY management can do is to FOCUS on 1 indication at a time. Plan well thought out trials, bring in REAL experts. Scott Kelly is Chairman of the Board, Chief Medical Officer, and now Head of Business Development??? what are his quals for bus dev?
Nader should be humble and take a pay cut to help the company in 2020 his compensation package was just under $10m... We have NOTHING We need to start acting like a small biotech and not get ahead of ourselves.
QUALITY not QUANTITY
What is there to talk about other than they control roughly 7% of the shares. And the names of the people who pledged their shares. There hasn't been anymore information provided, if there has I missed it. I've read everything from a reverse split, to selling the company cheap, Bruce Patterson as CEO, cydy purchasing incelldx. Maybe one or some could happen if they get the votes, maybe they get the votes and none happens. As I mentioned everyone gets to vote. Maybe some will vote to replace Nader but keep the current board of directors do he has no voting power. It's all rumor and speculation at this point until that group provides a written plan.
I have no idea what could or will happen, everyone is just speculating right now. Which is causing confusion and fud. Until we know something the 13d group should not be talked about. That's all I was saying ...
I think everyone just needs to focus on actual facts. The 13d group hasn't presented anything right now all these rumors are not being spread by them, but by people who are pro Nader.
They haven't stated a RS was going to happen, incelldx buyout. None of it.
That being said, everyone has a right to vote when the time comes, maybe the majority will vote to replace Nader but keep the current bod, if that happens then "they" don't have control and we get a better CEO???
Everyone just needs to wait and see what's presented, until then no sense in worrying.
Give it up, it's a scam. Do some research
I've been long for sometime, however that FDA piece started to make me question things. First we have never seen a full data set on any trial, the company only release top line. 2nd, and this is a big one for me, we finished the trials for HIV 3 years ago, and have yet to successfully submit the BLA, we have $87m waiting for us for acceptance, and then revenue on approval, they spent 10 years on these trials, and continually choose to start new trials in any indication they can think of. After Mahboob left, you have to wonder how bad that HIV trial data is, and if we need to re-do the trial. We just say back to back bad trial designs in CD-10 and CD-12, and that was with more seasoned professionals, who really knows what happened with HIV.
100% right
I believe they have to put something out as to allow shareholders to call in. I would think we see a proactive video before we have a CC
Based on what? It's an empty shell, the property is gone.
I think the only thing that happened was credibility was lost in your part.
They were planning on taking the property from sarissa resources, however that fell through and they ended up with an empty shell. So no digging, no mining, no gold
Yes, there was nothing new, however the presentation was geared to a group of oncologists that may have never heard of our drug. This was a cancer conference so he focused on CANCER doesn't matter the phase of the study.